MedPath

TISSEEL KIT VH 1.0

TISSEEL KIT VH 1.0

Discontinued
DIN Number

01949020

Drug Class

Human

Market Date

Dec 31, 1992

Company
HC

osterreichisches institut fur haemoderivate ges m.b.h.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01949020
AIG Number0952583001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
B02BD20 COMBINATIONS
Product Specifications
Dosage FormPowder For Solution ,  Liquid
Route of AdministrationTopical
AHFS Classification20:28.16
Health Canada Classification

ACTIVE INGREDIENTS (9)

ANTIHEMOPHILIC FACTOR (HUMAN)Active
Strength: 50 UNIT / ML
Monograph: ANTIHEMOPHILIC FACTOR (HUMAN)
APROTININ (BOVINE)Active
Strength: 300 UNIT / ML
Monograph: APROTININ (BOVINE)
CALCIUM CHLORIDEActive
Strength: .04 MMOL / ML
Monograph: CALCIUM CHLORIDE
FIBRINOGEN (HUMAN)Active
Strength: 110 MG / ML
Monograph: FIBRINOGEN (HUMAN)
PLASMAFIBRONECTIN (CIG)Active
Strength: 9 MG / ML
Monograph: PLASMAFIBRONECTIN (CIG)
PLASMINOGENActive
Strength: 120 MCG / ML
Monograph: PLASMINOGEN
PROTEINActive
Strength: 130 MG / ML
Monograph: PROTEIN
THROMBIN (BOVINE)Active
Strength: 500 UNIT / ML
Monograph: THROMBIN (BOVINE)
THROMBIN (BOVINE)Active
Strength: 4 UNIT / ML
Monograph: THROMBIN (BOVINE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.